DRAPER, Utah, Sept. 01, 2022 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health. NASHUA, N.H. (PRWEB) November 28, 2022 — Harbor Care’s Board of Directors has selected Henry Och as president and Chief Executive Officer. He will assume the day-to-day leadership of the company, which provides vital services, including housing and healthcare, to more than 5,000 New Hampshire community members statewide. LaQuandra Nesbitt will serve as executive director of a new Center for Population Health Sciences and Health Equity, senior associate dean and the bicentennial.

HONOLULU – The Hawai‘i State Department of Health (DOH) Harm Reduction Services Branch announced that Heather Lusk will receive the 2022 Suzanne Richmond-Crum Award. Heather is being honored for her outstanding contributions to increasing access to HIV/AIDS services in Hawai‘i. “Heather has dedicated her career to expanding access to HIV/AIDS services and advocating for health. . Georgetown’s board of directors welcomed new members, reviewed a balanced budget for the fiscal year 2022 and toured the university’s downtown facilities during its annual fall meeting in October.Deerfield Management Company, a New York City-based healthcare investment firm and Advancium Health Network, a public charity dedicated to advancing healthcare services and health equity through philanthropic investment, announced today the third annual XSeed Award, a program designed to support early-stage life science, minority- and women-led startups in New York City. A change from previous award seasons, this year, two life science startup companies will each be awarded up to $250,000.Over 144,000 adults in Northern Virginia are looking for therapy or counseling but aren’t able to access it.

. .

. This month the CDC and World Health Organization issued a report that 40 million children are at risk for measles globally. The news comes after a measles outbreak is steadily spreading among unvaccinated children in Columbus, OH. Infectious diseases expert say the outbreak was caused by low vaccination rates among children in the area. Measles can cause a painful rash, and nearly 20% of kids who contract the infection are hospitalized. Boston’s charitable dollar is now being stretched in new directions, will there be enough to go around in the future?.

Meet Pennsylvania’s most influential female leaders. .

European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy® for the Treatment of HIV in Pediatric Populations

EC Authorizes a Low-Dose Tablet for HIV Treatment in Virologically Suppressed Children at Least Two Years of Age and Weighing at Least 14 kg, Helping to Address a Critical Unmet Need – – Biktarvy Provides an Effective Therapy Choice for a Diverse Range of People Living with HIV, including Children with Limited Treatment Options – Gilead Sciences, Inc. today announced that the European Commission has authorized . Catch up with the news and key moments from the AMA House of Delegates’ meeting, which ran Nov. 12–15. Alfred E. Mann gift expands USC work at intersection of health sciences, engineering.The institute formerly known as the Appalachian Rural Health Institute has broadened its focus beyond rural health and expanded its reach beyond Appalachia. It now operates as the Appalachian Institute to Advance Health Equity Science (ADVANCE).

. DispatchHealth raised $330M; Sondermind bought Total Brain; Elizabeth Holmes gets 11 years in prison.

. Currently, the United States does not have any comprehensive federal laws or regulations that specifically regulate AI. However, as in other. In this 2-part episode of AMA Moving Medicine, experts from the AMA, FDA and CDC discuss tecovirimat, or TPOXX, for the treatment of monkeypox in infected individuals. Fourth Interim Analysis Shows Continued Clinically Meaningful Differentiation Across All Efficacy Measures, Including PFS, in Both Domvanalimab-Containing Arms Compared to the Anti-PD-1 Zimberelimab Monotherapy Arm in First-Line NSCLC Patients – – Data will be Presented on December 20, 2022 at the American Society of Clinical Oncology Monthly Plenary Series – – Three Phase 3 Domvanalimab Combination Studies .